{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:50:35Z","timestamp":1791546635723,"version":"4.3.4"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The feasibility and safety of a second course of boron neutron capture therapy (BNCT) are unknown. In this study, we retrospectively analyzed the treatment outcomes and toxicities in recurrent head and neck cancer (RHNC) patients who underwent BNCT twice at Southern TOHOKU BNCT Research Center. In total, 33 patients who underwent BNCT twice for RHNC at Southern TOHOKU BNCT Research Center between June 2020 and March 2024 were included. The indications for second BNCT were local recurrence or residual tumor after the first course. Eligible patients either declined salvage surgery or had no curative treatment options other than second BNCT. The median age was 65\u00a0years (range, 23\u201384\u00a0years), and the median interval from the first to the second BNCT was 4.1\u00a0months (range, 2.3\u201314.2\u00a0months). The median follow-up period after second BNCT was 27.3\u00a0months (range, 3.8\u201360.4\u00a0months), and the median survival time after second BNCT was 33.6\u00a0months. The 1-year\/2-year overall survival and local control after second BNCT were 81.8%\/57.1% and 38.3%\/22.3%, respectively. The response rates to the first and second courses of BNCT were 81.8% and 70%, respectively. Acute and late Grade 3 or higher toxicities were observed in 5 (15.1%) and 20 patients (60.6%), respectively. Only one patient developed Grade 5 aspiration pneumonia. A second course of BNCT developed a high incidence of late Grade 3 or higher toxicities with limited clinical benefit. Therefore, it may be considered only in carefully selected patients without alternative treatment options.<\/jats:p>","DOI":"10.1093\/jrr\/rrag053","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:26:56Z","timestamp":1784831216000},"page":"787-795","source":"Crossref","is-referenced-by-count":0,"title":["The feasibility and toxicity of the second course of boron neutron capture therapy in recurrent head and neck cancer patients"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-1366","authenticated-orcid":false,"given":"Yoshiaki","family":"Takagawa","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]},{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , 1 Hikarigaoka, Fukushima-shi, Fukushima 960-1295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Takai","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9711-1158","authenticated-orcid":false,"given":"Takashi","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Seto","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-9416","authenticated-orcid":false,"given":"Shinya","family":"Komori","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-9696","authenticated-orcid":false,"given":"Ryohei","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Motoyanagi","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8343-8037","authenticated-orcid":false,"given":"Takahiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku BNCT Research Center , 7-10 Yatsuyamada, Koriyama-shi, Fukushima 963-8052 ,","place":["Japan"]},{"name":"Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University , 1 Hikarigaoka, Fukushima-shi, Fukushima 960-1295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-9881","authenticated-orcid":false,"given":"Michitaka","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , 1 Hikarigaoka, Fukushima-shi, Fukushima 960-1295 ,","place":["Japan"]},{"name":"Department of Surgery, Southern Tohoku General Hospital , 7-115 Yatsuyamada, Koriyama-shi, Fukushima 963-8563 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University , 1 Hikarigaoka, Fukushima-shi, Fukushima 960-1295 ,","place":["Japan"]},{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University , 1 Hikarigaoka, Fukushima-shi, Fukushima 960-1295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2026100906563719400_ref1","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"key":"2026100906563719400_ref2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.semradonc.2025.02.009","article-title":"Reirradiation for locally recurrent head and neck cancer: state-of-the-art and future directions","volume":"35","author":"Phan","year":"2025","journal-title":"Semin Radiat Oncol"},{"key":"2026100906563719400_ref3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ((10)B) for recurrent or locally advanced head and neck cancer (JHN002): an open-label phase II trial","volume":"155","author":"Hirose","year":"2021","journal-title":"Radiother Oncol"},{"key":"2026100906563719400_ref4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ijrobp.2024.03.041","article-title":"Clinical results and prognostic factors in Boron Neutron Capture Therapy for recurrent squamous cell carcinoma of the head and neck under the Japan National Health Insurance System: a retrospective study of the initial 47 patients","volume":"120","author":"Hirose","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050869","article-title":"Safety of boron neutron capture therapy with Borofalan((10)B) and its efficacy on recurrent head and neck cancer: real-world Outcomes from nationwide post-marketing surveillance","volume":"16","author":"Sato","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026100906563719400_ref6","doi-asserted-by":"publisher","first-page":"110382","DOI":"10.1016\/j.radonc.2024.110382","article-title":"Efficacy and safety of boron neutron capture therapy for hypopharyngeal\/laryngeal cancer patients with previous head and neck irradiation","volume":"198","author":"Sato","year":"2024","journal-title":"Radiother Oncol"},{"key":"2026100906563719400_ref7","doi-asserted-by":"publisher","first-page":"108961","DOI":"10.1016\/j.apradiso.2019.108961","article-title":"Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center","volume":"156","author":"Kato","year":"2020","journal-title":"Appl Radiat Isot"},{"key":"2026100906563719400_ref8","doi-asserted-by":"publisher","first-page":"104818","DOI":"10.1016\/j.ejmp.2024.104818","article-title":"Retrospective analysis of treatment-positioning accuracy and dose error in boron neutron capture therapy using a sitting-position treatment system for head and neck cancer","volume":"126","author":"Komori","year":"2024","journal-title":"Phys Med"},{"key":"2026100906563719400_ref9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s12194-024-00833-7","article-title":"Evaluation of calculation accuracy and computation time in a commercial treatment planning system for accelerator-based boron neutron capture therapy","volume":"17","author":"Takeuchi","year":"2024","journal-title":"Radiol Phys Technol"},{"key":"2026100906563719400_ref10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2307\/3578136","article-title":"The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster","volume":"128","author":"Hiratsuka","year":"1991","journal-title":"Radiat Res"},{"key":"2026100906563719400_ref11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0360-3016(93)90533-2","article-title":"Derivations of relative biological effectiveness for the high-let radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo","volume":"27","author":"Coderre","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2307\/3578693","article-title":"Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin","volume":"138","author":"Fukuda","year":"1994","journal-title":"Radiat Res"},{"key":"2026100906563719400_ref13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2307\/3578951","article-title":"Comparative assessment of single-dose and fractionated boron neutron capture therapy","volume":"144","author":"Coderre","year":"1995","journal-title":"Radiat Res"},{"key":"2026100906563719400_ref14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2307\/3579926","article-title":"Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity","volume":"149","author":"Coderre","year":"1998","journal-title":"Radiat Res"},{"key":"2026100906563719400_ref15","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"2026100906563719400_ref16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.2016142043","article-title":"Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0","volume":"280","author":"Lodge","year":"2016","journal-title":"Radiology"},{"key":"2026100906563719400_ref17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"2026100906563719400_ref18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1001\/jamaoncol.2017.0973","article-title":"Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques","volume":"3","author":"Leeman","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026100906563719400_ref19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00066-015-0854-y","article-title":"Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck","volume":"191","author":"Dornoff","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"2026100906563719400_ref20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ijrobp.2016.07.037","article-title":"Reirradiation of recurrent and second primary head and neck cancer with proton therapy","volume":"96","author":"McDonald","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijrobp.2016.03.053","article-title":"Reirradiation of head and neck cancers with proton therapy: outcomes and analyses","volume":"96","author":"Phan","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ijrobp.2016.02.036","article-title":"Proton beam reirradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes","volume":"95","author":"Romesser","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref23","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1111\/ajco.12502","article-title":"Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer","volume":"13","author":"Hayashi","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"key":"2026100906563719400_ref24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00066-017-1129-6","article-title":"Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy","volume":"193","author":"Yamazaki","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"2026100906563719400_ref25","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijrobp.2017.06.012","article-title":"Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: a multi-institution cohort study by the MIRI collaborative","volume":"100","author":"Ward","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.radonc.2019.04.007","article-title":"Feasibility of re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy","volume":"136","author":"Hayashi","year":"2019","journal-title":"Radiother Oncol"},{"key":"2026100906563719400_ref27","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4143\/crt.2020.310","article-title":"Intensity-modulated radiotherapy-based reirradiation for head and neck cancer: a multi-institutional study by Korean Radiation Oncology Group (KROG 1707)","volume":"52","author":"Lee","year":"2020","journal-title":"Cancer Res Treat"},{"key":"2026100906563719400_ref28","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0360-3016(01)01745-X","article-title":"RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck","volume":"51","author":"Spencer","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref29","doi-asserted-by":"publisher","year":"2004","DOI":"10.1007\/0-306-48060-3_7"},{"key":"2026100906563719400_ref30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijrobp.2004.08.020","article-title":"Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I\/II trial","volume":"61","author":"Hehr","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.radonc.2006.02.003","article-title":"A phase II study of primary reirradiation in squamous cell carcinoma of head and neck","volume":"78","author":"Langendijk","year":"2006","journal-title":"Radiother Oncol"},{"key":"2026100906563719400_ref32","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","article-title":"Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911","volume":"25","author":"Langer","year":"2007","journal-title":"J Clin Oncol"},{"key":"2026100906563719400_ref33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00066-010-2082-9","article-title":"Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol","volume":"186","author":"Berger","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"2026100906563719400_ref34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00066-011-0040-9","article-title":"Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck: A prospective phase II trial","volume":"188","author":"Vormittag","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"2026100906563719400_ref35","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ijrobp.2014.11.023","article-title":"A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck","volume":"91","author":"Vargo","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026100906563719400_ref36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/annonc\/mdy018","article-title":"Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck","volume":"29","author":"Awan","year":"2018","journal-title":"Ann Oncol"},{"key":"2026100906563719400_ref37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ctro.2020.04.009","article-title":"Beyond reirradiation: efficacy and safety of three or more courses of radiation for head and neck malignancies","volume":"23","author":"Xu","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"2026100906563719400_ref38","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"2026100906563719400_ref39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"2026100906563719400_ref40","volume-title":"Radiation-Induced Skin Ulcer","author":"Manna","year":"2025"},{"key":"2026100906563719400_ref41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13014-025-02680-1","article-title":"Hyperbaric oxygen therapy for late radiation tissue toxicity injury after head and neck cancer: a systematic review of the literature","volume":"20","author":"El Hadji","year":"2025","journal-title":"Radiat Oncol"},{"key":"2026100906563719400_ref42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jocn.2012.09.011","article-title":"Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations","volume":"20","author":"Rahmathulla","year":"2013","journal-title":"J Clin Neurosci"},{"key":"2026100906563719400_ref43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ajco.12124","article-title":"Cerebral radiation necrosis","volume":"10","author":"Na","year":"2014","journal-title":"Asia Pac J Clin Oncol"},{"key":"2026100906563719400_ref44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","article-title":"A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic radiosurgery society recommendations","volume":"118","author":"Vellayappan","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/67\/5\/787\/69882645\/rrag053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/67\/5\/787\/69882645\/rrag053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:56:43Z","timestamp":1791543403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/67\/5\/787\/8740683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7,23]]},"published-print":{"date-parts":[[2026,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrag053","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,23]]}}}